Interaction of VariousEncapsulated Antipathogenic Drugs with Phospholipid Liposomes
Sally Mahmoud Helmy Mohamed AbdEl-Hamid;
Abstract
Antibiotics are so important for treating bacterial infections. Yet,
unfortunately bacteria nowadays are capable of mutating and developing
resistance to these antibiotics by time. They can easily evolve and change their
structure by self-encoding a new set of modified genes programmed to combat
the drug so the antibiotic becomes less effective towards it.
This antimicrobial resistance problem is becoming a global issue because
infections caused by these resistant microorganisms often fail to respond to
the standard treatment, resulting in prolonged illness and greater risk of death.
Therefore, the search for a new drug delivery system was an obligation. That
is why liposomes were introduced as an effective drug carrier.
Liposomes have proved to be an efficient drug delivery system. They are
capable of targeting drugs into desired tissues. This can decrease or even
demolish the cytotoxic effect of those drugs on healthy tissues and increase
the overall efficiency of those administrated drugs.
In this study, different antibiotics from the aminoglycosides and
cephalosporins families were encapsulated into diverse formulations of
phosphatidylcholine liposomes. Their size distributions and zeta potentials
were measured. Their physical characterization was followed by testing the
efficiency of the incorporated drug delivery on both gram +ve and gram –ve
bacteria. It was observed that DMPC liposomes had the most efficient drug
delivery into bacterial cells due to their very small size distributions.
FTIR spectroscopy also proved that all of the examined antibiotics could
be intercalated in both the aqueous moiety and the bilayer membrane of the
DMPC liposomes.
To conduct these experiments, various techniques were used. Dynamic
light scattering technique was used for the physical characterization of
liposomes in the Institute of Complex Systems ICS7 in Forchungszentrum
Jülich, Germany. The FTIR measurements were carried out in the research
institute of ophthalmology, Giza, Egypt. Finally, the microbiological
Abstract
VIII
experiments were carried out in the microbiology department, faculty of
science, Ain shams university, Cairo, Egypt.
All of the DMPC liposomal-antibiotics inspected had the smallest size
distributions and a higher antibacterial efficiency than the traditional
antibiotics in their free state. Aminoglycosides and cephalosporins proved
their ability to intercalate themselves in both the aqueous moiety and the
bilayer membrane of DMPC liposomes.
FTIR spectroscopy proved that most of the antibiotics interactions with the
liposome happened in the head (NH-OH) and phosphate group regions and
that cefotaxime induced the biggest interactions with the bilayer membrane of
the DMPC liposome prompting the highest conformational changes in it.
The encapsulated antibiotics concentrations could even be reduced into 2
and 4 times fold and still had better antibacterial effect than the traditional free
antibiotics.
unfortunately bacteria nowadays are capable of mutating and developing
resistance to these antibiotics by time. They can easily evolve and change their
structure by self-encoding a new set of modified genes programmed to combat
the drug so the antibiotic becomes less effective towards it.
This antimicrobial resistance problem is becoming a global issue because
infections caused by these resistant microorganisms often fail to respond to
the standard treatment, resulting in prolonged illness and greater risk of death.
Therefore, the search for a new drug delivery system was an obligation. That
is why liposomes were introduced as an effective drug carrier.
Liposomes have proved to be an efficient drug delivery system. They are
capable of targeting drugs into desired tissues. This can decrease or even
demolish the cytotoxic effect of those drugs on healthy tissues and increase
the overall efficiency of those administrated drugs.
In this study, different antibiotics from the aminoglycosides and
cephalosporins families were encapsulated into diverse formulations of
phosphatidylcholine liposomes. Their size distributions and zeta potentials
were measured. Their physical characterization was followed by testing the
efficiency of the incorporated drug delivery on both gram +ve and gram –ve
bacteria. It was observed that DMPC liposomes had the most efficient drug
delivery into bacterial cells due to their very small size distributions.
FTIR spectroscopy also proved that all of the examined antibiotics could
be intercalated in both the aqueous moiety and the bilayer membrane of the
DMPC liposomes.
To conduct these experiments, various techniques were used. Dynamic
light scattering technique was used for the physical characterization of
liposomes in the Institute of Complex Systems ICS7 in Forchungszentrum
Jülich, Germany. The FTIR measurements were carried out in the research
institute of ophthalmology, Giza, Egypt. Finally, the microbiological
Abstract
VIII
experiments were carried out in the microbiology department, faculty of
science, Ain shams university, Cairo, Egypt.
All of the DMPC liposomal-antibiotics inspected had the smallest size
distributions and a higher antibacterial efficiency than the traditional
antibiotics in their free state. Aminoglycosides and cephalosporins proved
their ability to intercalate themselves in both the aqueous moiety and the
bilayer membrane of DMPC liposomes.
FTIR spectroscopy proved that most of the antibiotics interactions with the
liposome happened in the head (NH-OH) and phosphate group regions and
that cefotaxime induced the biggest interactions with the bilayer membrane of
the DMPC liposome prompting the highest conformational changes in it.
The encapsulated antibiotics concentrations could even be reduced into 2
and 4 times fold and still had better antibacterial effect than the traditional free
antibiotics.
Other data
| Title | Interaction of VariousEncapsulated Antipathogenic Drugs with Phospholipid Liposomes | Other Titles | تفاعل مختلف العقاقير المٌحوصلة و المضاده للعامل المٌمرض مع الليبوزومات الفوسفوليبيدية | Authors | Sally Mahmoud Helmy Mohamed AbdEl-Hamid | Issue Date | 2016 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| G13819.pdf | 1.11 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.